Article info

Download PDFPDF

Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study

Authors

  1. Correspondence to Dr Antoine Thiery-Vuillemin; a.thieryvuillemin{at}mac.com
View Full Text

Citation

Thiery-Vuillemin A, Hvid Poulsen M, Lagneau E, et al
Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study

Publication history

  • Received May 11, 2018
  • Revised May 29, 2018
  • Accepted May 30, 2018
  • First published August 3, 2018.
Online issue publication 
August 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.